argenx - Koers, nieuws, agenda en adviezen van analisten

Grafiek argenx

argenx

ARGX | NL0010832176
Euronext Brussel

Aandeel toevoegen aan Mijn selectie

20,25 EUR -0,16 EUR (-0,78%)

23 oktober 2017 15:10

Vandaag

20,15

20,50

12 maanden

12,50

22,30

Laatste	20,25 €
Verschil	0,78 %
Tijd	15:10
Hoog	20,50 EUR
Laag	20,15 EUR
Open	20,50 EUR
Volume	3.662

Grafiek voor argenx

Sector

Biotechnologie

Agenda

26/10/2017 Trading update (3e kwartaal)
Volledige agenda »

Adviezen van analisten over argenx

Verkopen

Kopen

Gemiddeld koersdoel: 20,00 EUR

Details van de adviezen over argenx »

Laatste nieuws over argenx

26/09/2017 07:00 argenx launches Phase II proof-of-concept clinical trial of ARGX-113...

25/09/2017 12:45 argenx announces orphan drug designation for ARGX-113 for the...

22/09/2017 07:00 Invitation to the extraordinary shareholders' meeting

20/09/2017 07:00 argenx reaches 50% enrollment in Phase 2 clinical trial of ARGX-113...

24/08/2017 07:00 argenx reports second quarter business update and half-year 2017...

23/08/2017 07:00 argenx announces publication in Nature Medicine of preclinical data...

17/08/2017 07:00 argenx to host conference call & webcast to report second quarter...

08/08/2017 07:00 argenx to Present at Wedbush PacGrow Healthcare Conference

07/07/2017 07:00 argenx presents full data from ARGX-111 Phase Ib study in patients...

20/06/2017 07:00 argenx receives second preclinical milestone payment in collaboration...

14/06/2017 08:00 argenx presents update on Phase I data from ARGX-110 expansion study...